Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Total Shareholders’ Equity (Deficit)
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated  Other Comprehensive Income (Loss)
Noncontrolling Interests
Common stock, beginning balance (in shares) at Dec. 31, 2023     65,546,174          
Beginning balance at Dec. 31, 2023 $ (43,281) $ (43,509) $ 7 $ (951) $ 188,323 $ (233,791) $ 2,903 $ 228
Treasury stock, beginning balance (in shares) at Dec. 31, 2023       353,470        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 2,535 2,535     2,535      
Common stock issued for share-based awards (in shares)     32,550          
Shares repurchased for settlement of employee tax withholdings on share-based awards (in shares)       19,950        
Shares repurchased for settlement of employee tax withholdings on share-based awards (56) (56)   $ (56)        
Foreign currency translation, net of tax (672) (667)         (667) (5)
Net loss (8,096) (8,095)       (8,095)   (1)
Common stock, ending balance (in shares) at Mar. 31, 2024     65,578,724          
Ending balance at Mar. 31, 2024 $ (49,570) $ (49,792) $ 7 $ (1,007) 190,858 (241,886) 2,236 $ 222
Treasury stock, ending balance (in shares) at Mar. 31, 2024       373,420        
Common stock, beginning balance (in shares) at Dec. 31, 2024 67,002,370   67,002,370          
Beginning balance at Dec. 31, 2024 $ (188,714)   $ 7 $ (3,573) 161,619 (348,106) 1,339  
Treasury stock, beginning balance (in shares) at Dec. 31, 2024       728,739        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 2,912       2,912      
Common stock issued for share-based awards (in shares)     14,400          
Common issued for warrants exercised (in shares)     9,499,138          
Common stock issued for warrants exercised 117,780   $ 1   117,779      
Securities converted to common stock (in shares)     566,424          
Convertible preferred stock converted to common stock 2,071       2,071      
Foreign currency translation, net of tax 835           835  
Net loss $ (2,948)         (2,948)    
Common stock, ending balance (in shares) at Mar. 31, 2025 77,082,332   77,082,332          
Ending balance at Mar. 31, 2025 $ (68,064)   $ 8 $ (3,573) $ 284,381 $ (351,054) $ 2,174  
Treasury stock, ending balance (in shares) at Mar. 31, 2025 728,739     728,739